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Abstract
Background: Enterovirus (EV) infections are commonly associated with encephalitis and meningitis. Detection of
enteroviral RNA in clinical specimens has been demonstrated to improve the management of patients, by ruling
out other causes of disease.
Method: To develop a sensitive and reliable assay for routine laboratory diagnosis, we developed a real-time one
step reverse transcription polymerase chain reaction (RT-PCR) assay with minor groove binder probes and primers
modified with complementary locked primer technology (TMC-PCR). We checked the sensitivity of the developed
assay by comparing it to a previously published TaqMan probe real-time one-step RT-PCR (TTN-PCR) procedure
using enteroviral isolates, Enterovirus Proficiency panels from Quality Control on Molecular Diagnostics (QCMD-
2007), and clinical specimens from patients with suspected EV infections.
Results: One hundred clinical specimens from 158 suspected viral meningitis cases were determined to be positive
by the TMC-PCR assay (63.29%), whereas only 60 were found to be positive by the TTN-PCR assay (37.97%). The
positive and negative agreements between the TMC-PCR and TTN-PCR assays were 100% and 59.2%, respectively.
Conclusion: This data suggest that the TMC-PCR assay may be suitable for routine diagnostic screening from
patient suspected EV infection.
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Background
Enteroviruses (EVs) are among the most common and
important viruses infecting humans. EVs are associated
with diverse clinical syndromes, ranging from mild febrile
illness to severe central nervous system diseases, such as
aseptic meningitis and encephalitis, potentially leading to
paralysis [1,2]. Neonates and young children are at the
greatest risk of developing severe, and occasionally fatal,
enteroviral infections [3,4]. Serotypes of EVs have tradi-
tionally been classified into echoviruses, coxsackieviruses,
groups A and B, and polioviruses [5]. Currently, EV sub-
types are divided into five species (human enteroviruses
[HEV] A, B, C, D, and poliovirus) with differing molecular
and biological characteristics [6]. Laboratory methods
used for the diagnosis of enteroviral infection have chan-
ged substantially over time [7-9]. Initially, EVs were
detected exclusively by cell culture and identified by
neutralization [10]. In the mid-1990s, polymerase chain
reaction (PCR) methods that can detect all EVs were
introduced and have supplanted cell culture in many diag-
nostic laboratories [11-13]. Cell culture methods for the
detection of EVs are time-consuming, requiring, on aver-
age, 7-14 days for identification. Also, most coxsackievirus
group A viruses do not adapt to cells as well as other EVs
[14]. Although cell culture remains the gold standard for
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any medium, provided the original work is properly cited.the identification of EVs in suspected patients, molecular
methods such as reverse transcription PCR (RT-PCR),
real-time RT-PCR, and nucleic acid sequence-based
amplification offer more sensitive, specific, and rapid
results [15-17]. However diagnosis by RT-PCR also has
problems, including contamination from post-reaction
handling and variation in results depending on laboratory
staff. Several groups have described real-time RT-PCR
methods for the detection of EVs in cerebrospinal fluid
(CSF) [18-23].
This study was developed and validated a rapid, sensi-
t i v e ,a n dr e l i a b l er e a l - t i m eR T - P C Ra s s a yf o rt h er o u t i n e
identification of EVs using the TaqMan minor groove
binder (MGB) format combined complementary locked
primer (CLP) technology [24]: the TMC-PCR assay
[25,26]. After experiments to evaluate its analytical sensi-
tivity, specificity, and reproducibility, it was used with
clinical specimens from patients and the results were
compared to those using a previously published TaqMan
probe real-time one step RT-PCR (TTN-PCR [23]) assay.
Methods
Viruses and Controls
Five reference strains belonging to distinct genogroups
[enterovirus 71 (EV71), coxsackievirus B2 (CVB2), echo 30
(E30), coxsackievirus A24 (CVA24), and poliovirus type 1
( P 1 ) ]w e r eo b t a i n e df r o mt h eA m e r i c a nT y p eC u l t u r e
Collection (ATCC) and were used to optimize TTN-PCR
conditions and to evaluate analytical performance. Infectiv-
ity of viruses was assayed in microplates in serial 10-fold
dilutions (from 10
-4 to 10
-10) with four wells per dilution.
TCID50 titers were calculated according to the Kärber
method [27]. Enteroviral isolates including 25 serotypes (12
echovirus (E1, 3, 5-7, 9, 13, 14, 16, 1, 25 and 30), four cox-
sackievirus A (CVA 10, 16, 22 and 24), six coxsackievirus B
(CVB 1-6), poliovirus type 1 (P1) and two new enterovirus
(EV71 and 74) circulating between 1997 and 2005 in Korea
were used to evaluate the reactivity of the assay to various
serotypes of EVs. Enterovirus Proficiency panels from
Quality Control on Molecular diagnostics (QCMD-2007)
were also included to compare results from both assays.
Clinical samples
In total, 158 clinical specimens, collected from patients
with suspected viral meningitis between June and Sep-
tember 2008, were included for evaluation with both
real-time PCR assays.
Extraction of viral RNA
RNA was extracted from 150 μL samples with the GM
Viral Nucleic Acid Extraction Kit (GreenMate Biotech
Corp, Korea), according to the manufacturer’sp r o t o c o l
using automated machines for liquid handling (Tecan,
Switzerland). The GM Viral Nucleic Acid Extraction Kit
uses a silica-based extraction method [28]. RNA was
then recovered in 50 μL of nuclease-free water. It was
used immediately or stored at -70°C.
Primers and probe
The TMC-PCR assay for detecting EVs is based on Taq-
Man technology. However, to improve the sensitivity
and specificity for all enteroviruses, the primers and
probe described by Verstrepen et al. was modified [23].
The primer pair was modified with CLP technology
(iNtRON Biotechnology, Korea); the forward and reverse
primers had 5-mer nucleotides added in complementary
sequences at their 5’-ends. To develop the TMC-PCR,
the TaqMan probe was modified to an MGB-conjugated
hybridization probe and was shorter than that described
by Verstrepen et al.[ 2 3 ] .T h eT M C - P C Ru s e dt w op r i -
m e r s :N C R - c Fa n dN C R - c Rt h a td e s c r i b e db yH o n gJ
et al. [24]. The TaqMan MGB probe, referred to TMP,
was: FAM5’-CCGACTACTTTGGGTGTC-3’MGB-NFQ
(positions 541-558 of the CVB2 sequence; GenBank
accession number EF174469). It contains the reporter 6-
carboxyfluorescein (FAM) and the non-fluorescent
quencher (NFQ) dye.
Real-time One Step RT-PCR
TMC-PCR assay was performed using an ABI Prism
7900HT sequence detection system (Applied Biosys-
tems). Viral RNA was amplified in 25 μL reactions using
RT-PCR master mix (AgPath-ID one-step RT-PCR Kit;
Ambion, CA). Reactions were incubated at 45°C for
15 min, and then at 95°C for 10 min, followed by 45
cycles of 95°C for 15 s and 60°C for 40 s.
Results
Limits of detection and reproducibility
To determine the detection limit of the TMC-PCR and
TTN-PCR assays, serial dilutions of five reference strains
belonging to distinct serotypes (EV71, CVB2, E30,
CVA24, and P1) were tested. The highest positive dilu-
tion of CVB2, 0.5 TCID50/mL, corresponded to a Ct of
35.6, whereas the lowest dilution, 1 × 10
7 TCID50/mL,
corresponded to a Ct of 8.38 of P1. Each of the titrated
v i r u s e sw a sam e m b e ro fam a j o rE Vg r o u p .T h em i n i -
mum detectable amount of enteroviral RNA was equiva-
lent to 0.01 TCID50 in CVA24. The detection limit of the
end point was the same in the TMC-PCR and TTN-PCR
assays (data not shown).
Reproducibility was tested by analyzing a titrated P1
virus at least three times on different days (Table 1). In the
TMC-PCR assay, the Ct mean values of the 10
-2 (10
5
TCID50/mL) and 10
-3 (10
4 TCID50/mL) RNA extracts, per-
formed in duplicate in three different runs, were 21.55 and
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0.08 and 0.07, respectively. The Ct mean values of the 10
-5
(100 TCID50/mL) and 10
-6 (10 TCID50/mL) RNA extracts,
performed in duplicate in three different runs, were 30.65
and 33.95, respectively, with inter-assay standard deviations
of 0.86 and 0.80, respectively.
In the TTN-PCR assay, the Ct mean values of the 10
-2
(10
5 TCID50/mL) and 10
-3 (10
4 TCID50/mL) RNA
extracts, performed in duplicate in three different runs,
were 21.22 and 24.82, respectively, with intra-assay stan-
dard deviations of 0.24 and 0.16 respectively. The Ct
mean values of the 10
-5 (100 TCID50/mL) and 10
-6 (10
TCID50/mL) RNA extracts, performed in duplicate in
three different runs, were 29.05 and 32.62, respectively,
with inter-assay standard deviations of 1.89 and 2.09,
respectively.
Analytical sensitivity and specificity
All clinical isolates of 25 serotypes circulating between
1997 and 2007 in Korea of EVs could be detected and
there was no inconsistency between the qualitative
results generated by the two assays (TMC-PCR and
TTN-PCR). This confirms that the modifications to the
primers and probes did not affect the detectable reac-
tion to various EV serotypes (in other words, pan-
enterovirus).
From the results for the 12 proficiency panels (EV07)
from QCMD (Glasgow, Scotland), including various titers
of coxsackievirus B3 (CVB3), echovirus 11 (E11), entero-
virus 71 (EV71), echovirus 30 (E30), and poliovirus type 3
(P3), could be detected the genomes of EVs, including
three serotypes with different detection limits, depending
on the assay used (Table 2). In the each case of CVB3
(EV07-07 vs. EV07-12), E11 (EV07-03 vs. EV07-04) and
E30 (EV07-08 vs. EV07-09), at a 10-fold lower viral titer
than the panel, TMC-PCR ass a yp r o d u c e dap o s i t i v e
result, whereas TTN-PCR assay produced a negative. Pare-
chovirus type 3 in sample EV07-02 and EV07-11 was not
detected by either assay, confirming that both assays were
specific to EVs.
Table 1 Intra- and inter-assay reproducibility of the EV MGB/CLP (TMC-PCR) and TAMRA/NonCLP real time RT-PCR
(TTN-PCR)
Intra assay
a Inter assay
b
10
5 TCID50/mL 10
4 TCID50/mL 100 TCID50/mL 10 TCID50/mL
Assay Mean
c S.D
d Mean
c S.D
d Mean
c S.D
d Mean
c S.D
d
TTN-PCR
e 21.22 0.24 24.82 0.16 29.05 1.89 32.62 2.09
TMC-PCR
f 21.55 0.08 25.02 0.07 30.65 0.86 33.95 0.80
a Each Ct value was determined from eight replicates within a assay
b Assays were performed three times on different days in an independent manner
c Mean of threshold cycle (Ct) value
d Standard deviation
e TAMRA/NonCLP real time RT-PCR assay
f MGB/CLP real time RT-PCR assay.
Table 2 Result with Enterovirus real time quality control panels
Panel no. Serotype TCID50/0.05 mL
a TMC-PCR
b TTN-PCR
c
EV07-01 Coxsackievirus B3 50 P
d P
d
EV07-02 Parechovirus 3 5.6 N
e N
e
EV07-03 Echovirus 11 0.13 P
d N
e
EV07-04 Echovirus 11 1.3 P
d P
d
EV07-05 Negative 0 N
e N
e
EV07-06 Enterovirus 71 2.8 P
d P
d
EV07-07 Coxsackievirus B3 5 P
d P
d
EV07-08 Echovirus 30 2.5 P
d P
d
EV07-09 Echovirus 30 0.25 P
d N
e
EV07-10 Poliovirus type3 0.063 P
d P
d
EV07-11 Parechovirus 3 0.056 N
e N
e
EV07-12 Coxsackievirus B3 0.5 P
d N
e
a tissue culture infectious dose per 0.05 mL
b MGB/CLP real time RT-PCR assay
c TAMRA/NonCLP real time RT-PCR assay
d positive results
e negative results.
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specimens
A total of 158 clinical specimens from patients diagnosed
with meningitis were evaluated. Sixty were positive in
both TMC-PCR and TTN-PCR assays, whereas 40 in
total 158 samples were positive only in the TMC-PCR
assay. The results were consistent number of negative
results in both case 58/98 (Table 3). The clinical speci-
mens consisted of 102 CSF, 48 stool, and 8 throat swab
samples. To investigate assay results among different
types of specimens, the TMC-PCR and TTN-PCR assays
were compared using the 102 CSF samples tested; 62 and
29 samples were positive using the TMC-PCR and TTN-
PCR assays, respectively. Thirty-six of the 48 stool sam-
ples were positive using the TMC-PCR assay and 29
using the TTN-PCR assay. Of the throat swab samples, 2
of 8 were positive by both assays.
In all specimens, the positive and negative agreements
of the TTN-PCR assay and the TMC-PCR assay were
100% (60/60) and 59.2% (58/98), respectively. In CSF
specimens, the positive and negative agreements of the
T T N - P C Ra s s a ya n dt h eT M C - P C Ra s s a yw e r e1 0 0 %
(29/29) and 54.79% (40/73), respectively. In stool speci-
mens, the positive and negative agreements of the TTN-
P C Ra s s a ya n dt h eT M C - P C Ra s s a yw e r e1 0 0 %( 2 9 / 2 9 )
and 63.16% (12/19), respectively. In throat swab speci-
mens, the positive and negative agreements of the TTN-
PCR assay and the TMC-PCR assay were 100% (2/2)
and 100% (6/6), respectively.
Discussion
Several groups have developed and demonstrated mole-
cular diagnostic methods that are highly sensitive, speci-
fic, simple, and reproducible. In the field of virology,
real-time RT-PCR has become a standard diagnostic
method because of its rapid turnaround time, relatively
low risk of contamination, and ease of use [19,29].
This study modified a TTN-PCR published method
[23] and compared it to our modified assay, TMC-PCR,
for use as a routine diagnostic assay. TMC-PCR assay
detected the same region of the 5’-NCR as the traditional
Verstrepen amplicon. The primers used in this assay
combined previously reported CLP technology [24], a
probe modified at the 5’-terminal by MGB, and a
3’-terminal NFQ. These probes provided lower back-
grounds and a higher signal-to-noise ratio than other
hybridization probes [30]. MGB allows the design and
use of shorter probes, while maintaining a high melting
temperature, which may be an advantage in designing
probes for small conserved regions [25,26].
The results of the modified primers and probe using
the 2007 QCMD panel were compared. TMC-PCR assay
detected all EVs in the panels, except parechovirus. How-
ever, the TTN-PCR assay could not detect some EVs,
such as echovirus 11 and coxsackievirus B3, in the 2007
panel. These false negative results were in low viral titer
samples (Table 1). To test TMC-PCR for EVs, EV71,
CVB2, E30, CVA24, and P1, as example EV serotypes,
were used to determine the dynamic range, to optimize
real-time PCR conditions, and to evaluate analytical per-
formance. The detection limits for EV in both assays
were similar (data not shown). However, standard devia-
tions (SDs) of the intra-assay and inter-assay reproduci-
bility of the TMC-PCR and TTN-PCR assays were
different, particularly at low viral dilutions (Table 2).
Thus, TMC-PCR had better assay reproducibility.
To examine the analytical performances of the TMC-
PCR and TTN-PCR assays, a prospective study on clini-
cal samples was conducted. In 158 clinical samples from
patients with aseptic meningitis, enterovirus was
detected in 100 of 158 samples by TMC-PCR and 60 of
158 samples by TTN-PCR. A comparison of the TMC-
PCR and TTN-PCR assays revealed 40 discrepant sam-
ples (Table 3), 33 (82.5%) of which were CSF specimens.
When separately analyzed using CSF specimens, the
positive and negative agreements between TMC-PCR
and TTN-PCR were 100% and 54.79%, respectively.
Then the GeneXpert Enterovirus Assay (GXEA; Cep-
heid, Sunnyvale, CA) were performed with the 40 dis-
crepant samples to confirm the results as false negatives
(data not shown). The results were matched to the
results of the TMC-PCR assay. To check the false
Table 3 Comparison of results of MGB/CLP (TMC-PCR) and TAMRA/NonCLP real time RT-PCR (TTN-PCR) in different
types of specimens
TTN-PCR
a
CSF
(n = 102)
Stool
(n = 48)
Throat swab
(n = 8)
All specimens
(n = 158)
+ - + - + - + -
TMC-PCR
b + 29 33 29 7 2 0 60 40
- 0 40 0 12 0 6 0 58
Totals 29 73 29 19 2 6 60 98
a TAMRA/NonCLP real time RT-PCR assay
b MGB/CLP real time RT-PCR assay.
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virus Assay (GXEA) with positive samples from TMC-
PCR assay. There were no discord results between
TMC-PCR and GXEA (data not shown).
The differences in viral titer were compared to the Ct
mean values of CSF-positive results. The Ct mean values
from TMC-PCR and TTN-PCR of positive CSF specimens
were 34.84 and 32.82, respectively. The TTN-PCR was
lower than TMC-PCR in terms of the absolute value of Ct,
but the rate of positive TMC-PCR was higher than in the
TMC-PCR assay. The results in stool specimens showed
the same pattern, despite the absolute mean value of Ct
differed between TMC-PCR (30.19) and TTN-PCR
(28.91). Although TMC-PCR assay has better sensitivity
compared with TTN-PCR assay, the Ct vale of TMC-PCR
assay in certain sample is higher than that of TNC-PCR
assay. The Ct value is not only factor to determine the
sensitivity. In our results, TMC-PCR assay has slightly
higher Ct than TTN-PCR assay but very lower standard
deviation (SD) compared with TTN-PCR assay in low viral
titers at inter assay (Table 1). It means that TMC-PCR
assay can produce stable diagnostic result in the specimen
with low viral titers such as CSF. We can confirm the high
sensitivity in the low titer proficiency sample in the Table
2 based on stability induced by CLP and MGB technolo-
g i e s .F o re x a m p l ei nt h eT a b l e2 ,T M C - P C Ra s s a yp r o -
duced a positive result, whereas TTN-PCR assay produced
a negative result at a 10-fold lower viral titer than the
panel: CVB3 (EV07-07 vs. EV07-12), E11 (EV07-03 vs.
EV07-04) and E30 (EV07-08 vs. EV07-09). We also evalu-
ate the sensitivity of assay developed in this study using
clinical samples and confirm the high sensitivity of TMC-
PCR assay (62/73) in the CSF sample than TTN-PCR
assay (29/73). Conclusively TMC-PCR assay has slightly
higher Ct value in the certain sample with high purity (cul-
ture supernatant or pure gene serial diluents), but can pro-
duce stable diagnostic results at the clinical sample with
low viral titers.
The results reported that the TMC-PCR assay is a bet-
ter routine diagnostic method for EV meningitis,
because of the low quantities of viral RNA in CSF speci-
mens, not only rapid and accurate results, and may be a
useful molecular screening method.
Conclusion
This study revealed that TMC-PCR assay could give
reliable results and showed better reproducibility for
routine laboratory diagnosis. Also technical modification
of primer provided to increase sensitivity. Our data sug-
gest that TMC-PCR assay may be more suitable to rou-
tine diagnostic assay for EV detection from clinical
specimens even though TMC-PCR assay was not the
novel real-time RT-PCR assay.
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